nejm glp 1 Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during procedures that require sedation. A randomized trial takes a closer look Orforglipron, an Oral Small-Molecule GLP-1
Description
A component of the Gila monsters venoma peptide known as exendin-4is being explored for new treatments for Alzheimers disease, diabetes, and other diseases.

From diabetes breakthroughs to weight-loss blockbusters, GLP-1 peptide APIs like Semaglutide and Tirzepatide are not just transforming patient caretheyre reshaping global strategies, reengineering supply chains, and redefining commercial po

Individual responses can vary

This overnight oats recipe is a quick, balanced breakfast option, ideal for those with a busy morning routine

Alzheimers disease (AD) is the most prevalent cause of dementia worldwide, disproportionately affecting women and lacking effective disease-modifying therap...

iBio may have the best R/R in myostatin inhibition, but the market hasn't realized it is no longer a struggling immuno-oncology company.